Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3542
-0.006-1.67%
Last update: Jan 12, 11:53 AM
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BioAtla (BCAB) stock?
You can purchase shares of BioAtla (NASDAQ:BCAB) through any online brokerage.
Who are BioAtla (BCAB) competitors?
Other companies in BioAtla’s space includes: Serina Therapeutics Inc (AMEX:SER), Intensity Therapeutics Inc (NASDAQ:INTS), Nanoviricides Inc (AMEX:NNVC), Lunai Bioworks Inc (NASDAQ:LNAI) and Palatin Technologies Inc (AMEX:PTN).
What is the forecast, or price target, for BioAtla (BCAB) stock?
BioAtla has a consensus price target of $11.00.
What is the current price for BioAtla (BCAB)?
The stock price for BioAtla (NASDAQ: BCAB) is $0.3542 last updated January 12, 2026 at 11:53 AM EST.
Does BioAtla (BCAB) pay a dividend?
There are no upcoming dividends for BioAtla.
When is BioAtla (NASDAQ:BCAB) reporting earnings?
BioAtla does not have any upcoming earnings scheduled.
Is BioAtla (BCAB) going to split?
There is no upcoming split for BioAtla.
What sector and industry does BioAtla (BCAB) operate in?
BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
